Home >> Conferences
Magnelle-PoweringTM of therapeutic cells can lower the costs of translational studies, reduce failures, and accelerate commercialization of R&D pipelines. Data gathered from cell tracking using MRI addresses regulatory requirements while also providing data on important clinical readouts. For example, Magnelle powered cells can be used to assess cell delivery, confirm engraftment and viability in vivo, define dosing, and eventually track therapeutic durability in individual patients. 

We are currently looking for:
  • Distributors and business partners to support commercialization of research-use only products
  • Cell therapy companies interested in co-development of Magnelle-powered cell therapies for human use
If interested in learning more about any of these opportunities, please contact us at BD@bellbiosystems.com.
Visit Us At The Following Conferences
Contact Us Sitemap Terms of Use
Follow Bell Biosystems
© 2018 Bell Biosystems. All rights are reserved
Website Security Test